Atıf İçin Kopyala
Sag E., Akal F., Atalay E., Akca Ü., Demir S., Demirel D., ...Daha Fazla
Rheumatology (Oxford, England), cilt.59, ss.3324-3329, 2020 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
59
-
Basım Tarihi:
2020
-
Doi Numarası:
10.1093/rheumatology/keaa121
-
Dergi Adı:
Rheumatology (Oxford, England)
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CINAHL, EMBASE, International Pharmaceutical Abstracts, MEDLINE
-
Sayfa Sayıları:
ss.3324-3329
-
Anahtar Kelimeler:
colchicine, resistant, intolerant, FMF, anakinra, canakinumab, anti-IL1, HELIOS, FAMILIAL MEDITERRANEAN FEVER, CANAKINUMAB, ANAKINRA, CHILDREN, EFFICACY
-
Hacettepe Üniversitesi Adresli:
Evet
Özet
Objectives. FMF is a prototype of autoinflammatory diseases associated with excess IL1 production. Anti-IL1 treatments are the first-line alternatives in colchicine-resistant/intolerant FMF patients. We aimed to investigate the efficacy and safety of anti-IL1 treatment in paediatric FMF patients in our local [Hacettepe univErsity eLectronlc research fOrmS (HELIOS)] registry.